Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cambridge

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|July 1, 1984
Aetiology and pathogenesis of inflammatory muscle diseaseG Cambridge
British Medical Journal (Clinical Research Ed.)|October 11, 1986
Licensed to killG Cambridge
British Journal of Hospital Medicine|November 3, 1993
Clinical use of antineutrophil cytoplasmic antibodiesB Leaker, G Cambridge
Postgraduate Medical Journal|February 1, 1990
Anti-neutrophil cytoplasmic antibodies and vasculitisB Leaker, G Cambridge
British Journal of Rheumatology|May 6, 1998
Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigenJ C Edwards, G Cambridge
British Journal of Biomedical Science|December 1, 1996
Autoantibodies to neutrophil granule proteins: pathogenic potential in vasculitis?I C Locke, G Cambridge
Rheumatology (Oxford, England)|March 21, 2001
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytesJ C Edwards, G Cambridge
Clinical and Experimental Immunology|April 1, 1981
The uptake of tritium-labelled carnitine by monolayer cultures of human fetal muscle and its potential as a label in cytotoxicity studiesG Cambridge, C M Stern
Molecular Immunology|May 28, 2004
An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascadeM J Hayes, G Cambridge
Rheumatology (Oxford, England)|October 29, 2004
Prospects for B-cell-targeted therapy in autoimmune diseaseJ C W Edwards, G Cambridge
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|July 1, 1984
Aetiology and pathogenesis of inflammatory muscle diseaseG Cambridge
British Medical Journal (Clinical Research Ed.)|October 11, 1986
Licensed to killG Cambridge
British Journal of Hospital Medicine|November 3, 1993
Clinical use of antineutrophil cytoplasmic antibodiesB Leaker, G Cambridge
Postgraduate Medical Journal|February 1, 1990
Anti-neutrophil cytoplasmic antibodies and vasculitisB Leaker, G Cambridge
British Journal of Rheumatology|May 6, 1998
Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigenJ C Edwards, G Cambridge
British Journal of Biomedical Science|December 1, 1996
Autoantibodies to neutrophil granule proteins: pathogenic potential in vasculitis?I C Locke, G Cambridge
Rheumatology (Oxford, England)|March 21, 2001
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytesJ C Edwards, G Cambridge
Clinical and Experimental Immunology|April 1, 1981
The uptake of tritium-labelled carnitine by monolayer cultures of human fetal muscle and its potential as a label in cytotoxicity studiesG Cambridge, C M Stern
Molecular Immunology|May 28, 2004
An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascadeM J Hayes, G Cambridge
Rheumatology (Oxford, England)|October 29, 2004
Prospects for B-cell-targeted therapy in autoimmune diseaseJ C W Edwards, G Cambridge
Pageof 7